Veradigm - MDRX STOCK NEWS

Seminal Capital Holdings announces key appointments to its Seminal Healthcare team, including Victor Kats, Mark Miller, and Lindsey Watson. These professionals bring extensive experience in healthcare technology and investment. Kats, with over 25 years in the industry, previously led the Healthcare Technology Practice at Ascension Ventures. Miller and Watson also come with a wealth of expertise from notable firms. Seminal Healthcare aims to enhance its impact investing focus and provide strategic support to healthcare companies.

Veradigm and CareMetx announced a new partnership to enhance the specialty medication approval process. The integration will allow CareMetx clients to access Veradigm's AccelRx automated solutions directly, aiming to reduce patient wait times and streamline administrative burdens. A 2020 survey indicated that 90% of physicians believe easier prescription fulfillment improves adherence, highlighting the importance of this collaboration. This partnership aligns with Veradigm's commitment to transforming healthcare delivery and improving patient outcomes.

Allscripts (NASDAQ: MDRX) has been selected as an innovation partner by Eastern Health, the largest health authority in Newfoundland and Labrador. This partnership aims to enhance healthcare services, improve patient care, and promote economic development in the region. The collaboration will leverage Allscripts' Open Development Program, allowing local developers and startups to innovate within its healthcare platform. Both entities are committed to improving health system efficiencies and creating new solutions that benefit patients and the broader healthcare community.

Allscripts (NASDAQ: MDRX) held the Advancing Health Equity Using Social Determinants of Health Developer Challenge, emphasizing the importance of sharing social determinants of health (SDOH) information to improve healthcare equity. Keynote speaker Dr. Micky Tripathi discussed efforts to combat health inequities. Eight developers presented solutions aimed at enhancing care through SDOH data integration. The challenge was won by Patient Orator, which aims to bridge the communication gap between patients and providers. Allscripts continues to innovate in healthcare technology to facilitate better patient outcomes.

Allscripts Healthcare Solutions (MDRX) reported a strong financial performance for Q2 2021, achieving bookings of $180 million, up from $164 million in Q2 2020. Revenue rose slightly to $374 million, with GAAP net income of $22 million compared to a loss of $8 million the previous year. Non-GAAP diluted earnings per share increased to $0.23 from $0.17. Adjusted EBITDA grew to $69 million, reflecting improved operational efficiency. The company revised its 2021 guidance, raising expected adjusted EBITDA to between $265-$275 million and free cash flow to $115-$125 million, while affirming revenue expectations of $1.5 billion.

Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) will release its financial results for Q2 2021 on August 5, 2021, after market close. A conference call will be held at 4:30 PM ET to discuss the earnings. Investors can access the announcement on the Allscripts investor relations website. For those wishing to participate, the conference call can be joined via phone using Conference ID #13721061. A replay will be available for four weeks following the call. Allscripts is focused on healthcare information technology solutions to enhance clinical and operational outcomes.

Veradigm and PRA Health Sciences have launched a groundbreaking electronic healthcare records-based clinical research network, accessible to over 25,000 physicians and 40 million patients in the U.S. This initiative aims to integrate clinical research with healthcare delivery, enabling broader patient participation in clinical trials. Utilizing Veradigm’s StudySource platform and PRA’s eSource technology, the partnership seeks to streamline trial processes and improve data quality. The goal is to enhance patient outcomes while reducing costs for all stakeholders.

Allscripts' Leigh Burchell has received the HIMSS21 Most Influential Women in Health IT Award. This award acknowledges women in health technology who significantly influence the field. Burchell oversees Policy and Government Affairs at Allscripts, advocating for legislative interests and engaging in industry discussions on health data and equity.

Her recognition will take place at the HIMSS Global Conference & Exhibition in Las Vegas from August 9-13, 2021. Burchell expressed her gratitude for the acknowledgment and highlighted the importance of health IT in enhancing patient care.

Allscripts Healthcare Solutions has announced a new share repurchase program approved by its Board of Directors, allowing the buyback of up to $350 million of its common stock. This program replaces the previous authorization of $300 million, which was fully utilized by the company. Allscripts emphasizes its strong financial performance and balance sheet as enabling factors for this expansion. The repurchase will be conducted in the open market or through negotiated transactions, with no set termination date.